Get the Daily Brief
Latest Biotech News
PanMAN shrinks pangenomes... storage bottleneck eased
Researchers introduced PanMAN (Pangenome Mutation‑Annotated Network), a new data structure and compression method that encodes phylogenies, mutations and whole‑genome alignments to dramatically...
AI‑powered CLASSIC maps genetic design space... millions of circuits
A Rice University team unveiled CLASSIC, a platform that combines long‑ and short‑read sequencing with AI/ML design to generate and map hundreds of thousands to millions of genetic circuit...
ImmunityBio touts durable responses in off‑the‑shelf CAR‑NK trials
ImmunityBio reported durable complete responses of up to 15 months in recipients of its off‑the‑shelf CAR‑NK cell therapy, citing cases across ongoing trials and highlighting the potential of...
BloodPAC issues MRD validation protocols – Veracyte targets TrueMRD launch
The BloodPAC consortium published standardized analytical validation protocols for tumor‑informed circulating tumor DNA (ctDNA) assays to guide MRD (minimal residual disease) test developers on...
Boston Scientific swings for the fences — $14.5B Penumbra buy
Boston Scientific announced a definitive agreement to acquire Penumbra for about $14.5 billion, moving decisively into thrombectomy and embolization markets. The deal combines Boston Scientific’s...
Tecvayli extends survival — J&J’s Phase 3 shows earlier use benefit
Johnson & Johnson reported Phase 3 results showing Tecvayli improved key outcomes when moved earlier in the multiple myeloma treatment sequence. In the MajesTEC-9 trial the dual‑targeting antibody...
Lilly targets quick review — oral GLP-1 on track as FDA eases labels
Eli Lilly said the FDA is expected to decide on its oral obesity candidate orforglipron in Q2 2026 after granting a national-priority fast review, positioning the pill to follow injectables into...
Liquid biopsy standards and readouts — Delfi previews pivotal lung data
Delfi Diagnostics outlined a roadmap at JPM for multiple pivotal readouts in 2026 tied to FirstLook Lung, its cfDNA fragmentomics lung‑cancer screening assay, and flagged plans to use those data...
Cell-therapy scale-up — Cellares takes Leiden lease as Agenus secures U.S. capacity
Cellares signed a long‑term lease for a Smart Factory at Leiden Bio Science Park to serve as its European headquarters and expand automated cell‑therapy manufacturing capacity. The facility will...
Lab AI and automation: instruments meet validated workflows
Thermo Fisher announced a strategic collaboration with NVIDIA to embed AI across scientific instruments, lab software and data infrastructure, aiming to accelerate lab automation, improve...
JPM stress test — investor optimism meets uneven financing recovery
The J.P. Morgan Healthcare Conference showed renewed optimism but also scrutiny over whether deal and funding momentum will persist; attendees flagged fewer headline M&A deals and more targeted...
Chemical reprogramming: human T cells turned to pluripotency
A team led by Wang et al. published a chemical reprogramming method in Cell Research that converts human T cells into pluripotent stem cells without introducing exogenous genetic factors. The...
Spatial biology accelerates — Ariadne.ai builds TumorTwin as multiomics reveals immune maps
Ariadne.ai secured €518,000 to develop TumorTwin, a 3D spatial-multiomics virtual tumor model intended to simulate glioblastoma behavior and predict responses to single and combination therapies....
AI designs working gene circuits — CLASSIC maps genetic design space
Researchers unveiled CLASSIC, an ultra‑high‑throughput platform that combines long- and short‑read sequencing with AI/ML to design, synthesize and screen millions of genetic circuit variants; the...
Tecvayli survival win – J&J pushes antibody earlier in myeloma
Johnson & Johnson reported two Phase 3 data sets showing Tecvayli (a bispecific T-cell engager) produced substantial clinical benefits when used earlier in multiple myeloma. In MajesTEC-9, J&J...
Boston Scientific to buy Penumbra for $14.5B – Medtech consolidation returns
Boston Scientific announced a definitive agreement to acquire Penumbra for about $14.5 billion, aiming to broaden its portfolio into thrombectomy and embolization devices. The deal will pay $374...
Thermo Fisher taps NVIDIA: AI to power smarter labs and instruments
Thermo Fisher Scientific and NVIDIA struck a strategic collaboration to integrate NVIDIA’s AI platform into Thermo Fisher instruments and lab software, aiming to automate workflows and accelerate...
Novo Nordisk Foundation backs BII with up to $857M – scaling Europe’s spinouts
The Novo Nordisk Foundation committed up to DKK 5.5 billion (about $857 million) to the BioInnovation Institute (BII) from 2026–2035 to expand startup creation, scale operations, and broaden BII’s...
Cellares secures Leiden site — expands automated cell therapy manufacturing in Europe
Cellares signed a long-term lease for a Smart Factory at Leiden Bio Science Park to establish its European integrated development and manufacturing organization (IDMO) hub. The facility—about...
Ariadne.ai to build TumorTwin – spatial multiomics goes virtual
Ariadne.ai won a €518,000 grant to develop TumorTwin, a virtual 3D model built from spatial multiomics to simulate glioblastoma behavior and therapy responses. The company plans a prototype within...